Plus therapeutics to present at the h.c. wainwright 25th annual global investment conference

Austin, texas, aug. 30, 2023 (globe newswire) -- plus therapeutics, inc. (nasdaq: pstv), a clinical-stage pharmaceutical company developing targeted radiotherapeutics with advanced platform technologies for central nervous system cancers, announced today that marc hedrick, m.d., president and chief executive officer, will present at the h.c. wainwright 25th annual global investment conference on tuesday, september 12, 2023 at 3:00 p.m. et at the lotte new york palace in new york, ny.
pstv Ratings Summary
pstv Quant Ranking